Novel Therapies for Essential Tremor

This study has been completed.
Sponsor:
Information provided by:
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00018564
First received: July 3, 2001
Last updated: January 20, 2009
Last verified: December 2004
  Purpose

This clinical research program is designed to evaluate medications as new treatments for essential tremor. Essential tremor is a common condition with few available therapies.


Condition Intervention Phase
Essential Tremor
Drug: treatments for essential tremor
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Novel Therapies for Essential Tremor

Resource links provided by NLM:


Further study details as provided by Department of Veterans Affairs:

Study Start Date: October 2000
Estimated Study Completion Date: September 2003
Detailed Description:

Each medication will be evaluated for effectiveness against tremor in a randomized, placebo-controlled, cross-over, double blind clinical research trial. Tremor will be assessed with accepted rating scales and accelerometry

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  1. Diagnosis of essential tremor.
  2. Tremor rating scale score 3 or one or both upper extremities
  3. Unsatisfactory response to primidone or to propanolol
  4. Not taking tremor-inducing drug
  5. Able to comply with visits
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00018564

Locations
United States, California
VA Greater Los Angeles Healthcare System
Los Angeles, California, United States, 90073
Sponsors and Collaborators
Investigators
Investigator: Fredricka Martin, Ph.D.
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00018564     History of Changes
Other Study ID Numbers: NEUD-048-00S
Study First Received: July 3, 2001
Last Updated: January 20, 2009
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Essential Tremor
Tremor
Central Nervous System Diseases
Dyskinesias
Movement Disorders
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms

ClinicalTrials.gov processed this record on October 20, 2014